Mark A. Velleca G1 Therapeutics, Inc. (GTHX) insider trading activity

GTHX Quotes by TradingView

Mark A. Velleca is of G1 Therapeutics, Inc.. Currently has a direct ownership of 116,000 shares of GTHX, which is worth approximately $829,400. The most recent transaction as insider was on Aug 08, 2023, when has been sold 60,000 shares (Common Stock) at a price of $2.01 per share, resulting in proceeds of $120,599. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 116K
0% 3M change
0% 12M change
Total Value Held $829,400

Mark A. Velleca Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 08 2023
SELL
Open market or private sale
$120,599 $2.01 p/Share
60,000 Reduced 34.09%
116,000 Common Stock
Aug 08 2023
BUY
Exercise of conversion of derivative security
$21,000 $0.35 p/Share
60,000 Added 33.57%
118,714 Common Stock
Oct 18 2022
SELL
Open market or private sale
$175,500 $11.7 p/Share
15,000 Reduced 11.45%
116,000 Common Stock
Oct 18 2022
BUY
Exercise of conversion of derivative security
$5,850 $0.39 p/Share
15,000 Added 10.27%
131,000 Common Stock
Sep 20 2022
SELL
Open market or private sale
$270,000 $13.5 p/Share
20,000 Reduced 14.71%
116,000 Common Stock
Sep 20 2022
BUY
Exercise of conversion of derivative security
$7,800 $0.39 p/Share
20,000 Added 12.82%
136,000 Common Stock
Aug 16 2022
SELL
Open market or private sale
$1,011,200 $12.64 p/Share
80,000 Reduced 40.82%
116,000 Common Stock
Aug 16 2022
BUY
Exercise of conversion of derivative security
$31,200 $0.39 p/Share
80,000 Added 28.99%
196,000 Common Stock
Feb 07 2022
BUY
Exercise of conversion of derivative security
$5,850 $0.39 p/Share
15,000 Added 11.45%
116,000 Common Stock
Nov 09 2021
BUY
Exercise of conversion of derivative security
$15,600 $0.39 p/Share
40,000 Added 28.37%
101,000 Common Stock
Jul 15 2021
SELL
Open market or private sale
$184,900 $18.49 p/Share
10,000 Reduced 14.08%
61,000 Common Stock
Jul 15 2021
BUY
Exercise of conversion of derivative security
$3,900 $0.39 p/Share
10,000 Added 12.35%
71,000 Common Stock
Jul 14 2021
SELL
Open market or private sale
$190,800 $19.08 p/Share
10,000 Reduced 14.08%
61,000 Common Stock
Jul 14 2021
BUY
Exercise of conversion of derivative security
$3,900 $0.39 p/Share
10,000 Added 12.35%
71,000 Common Stock
Jul 13 2021
SELL
Open market or private sale
$194,500 $19.45 p/Share
10,000 Reduced 14.08%
61,000 Common Stock
Jul 13 2021
BUY
Exercise of conversion of derivative security
$3,900 $0.39 p/Share
10,000 Added 12.35%
71,000 Common Stock
Jun 17 2021
SELL
Open market or private sale
$217,700 $21.77 p/Share
10,000 Reduced 14.08%
61,000 Common Stock
Jun 17 2021
BUY
Exercise of conversion of derivative security
$3,900 $0.39 p/Share
10,000 Added 12.35%
71,000 Common Stock
Jun 16 2021
SELL
Open market or private sale
$217,400 $21.74 p/Share
10,000 Reduced 14.08%
61,000 Common Stock
Jun 16 2021
BUY
Exercise of conversion of derivative security
$3,900 $0.39 p/Share
10,000 Added 12.35%
71,000 Common Stock
Jun 15 2021
SELL
Open market or private sale
$223,900 $22.39 p/Share
10,000 Reduced 14.08%
61,000 Common Stock
Jun 15 2021
BUY
Exercise of conversion of derivative security
$3,900 $0.39 p/Share
10,000 Added 12.35%
71,000 Common Stock
May 25 2021
BUY
Exercise of conversion of derivative security
$7,800 $0.39 p/Share
20,000 Added 24.69%
61,000 Common Stock
May 13 2021
SELL
Open market or private sale
$205,400 $20.54 p/Share
10,000 Reduced 19.61%
41,000 Common Stock
May 13 2021
BUY
Exercise of conversion of derivative security
$3,900 $0.39 p/Share
10,000 Added 16.39%
51,000 Common Stock

Also insider at

BDTX
Black Diamond Therapeutics, Inc. Healthcare
PRESIDENT & CEO
MAV

Mark A. Velleca

Research Triangle Park, NC

Track Institutional and Insider Activities on GTHX

Follow G1 Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GTHX shares.

Notify only if

Insider Trading

Get notified when an G1 Therapeutics, Inc. insider buys or sells GTHX shares.

Notify only if

News

Receive news related to G1 Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on GTHX